1 post
@nikon_news Heartseed Announces First Patient Dosed in a Phase I/II EMERALD Study with HS-005 - a Cell Therapy Administered via Catheter, Designed to Restore Heart Function in People with Severe Heart Failure <br>Cardiomyocyte Spheroids of HS-005 are Manufactured by Nikon CeLL innovation #HealthTech #Biotech #MedicalInnovation